BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of $652.40 million. The enterprise value is $586.79 million.
| Market Cap | 652.40M |
| Enterprise Value | 586.79M |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 40.03 million shares outstanding. The number of shares has increased by 13.91% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 40.03M |
| Shares Change (YoY) | +13.91% |
| Shares Change (QoQ) | +7.02% |
| Owned by Insiders (%) | 17.30% |
| Owned by Institutions (%) | 25.86% |
| Float | 27.78M |
Valuation Ratios
The trailing PE ratio is 86.13 and the forward PE ratio is 53.06.
| PE Ratio | 86.13 |
| Forward PE | 53.06 |
| PS Ratio | 12.49 |
| Forward PS | 3.05 |
| PB Ratio | 8.92 |
| P/TBV Ratio | 8.92 |
| P/FCF Ratio | 43.07 |
| P/OCF Ratio | 37.31 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 114.70, with an EV/FCF ratio of 38.74.
| EV / Earnings | 77.46 |
| EV / Sales | 11.24 |
| EV / EBITDA | 114.70 |
| EV / EBIT | 135.74 |
| EV / FCF | 38.74 |
Financial Position
The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.73 |
| Quick Ratio | 3.23 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 1.16 |
| Debt / FCF | 0.45 |
| Interest Coverage | 2.77 |
Financial Efficiency
Return on equity (ROE) is 11.18% and return on invested capital (ROIC) is 45.57%.
| Return on Equity (ROE) | 11.18% |
| Return on Assets (ROA) | 2.60% |
| Return on Invested Capital (ROIC) | 45.57% |
| Return on Capital Employed (ROCE) | 4.77% |
| Weighted Average Cost of Capital (WACC) | 6.11% |
| Revenue Per Employee | $435,208 |
| Profits Per Employee | $63,125 |
| Employee Count | 120 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.35 |
Taxes
In the past 12 months, BrainsWay has paid $135,000 in taxes.
| Income Tax | 135,000 |
| Effective Tax Rate | 1.75% |
Stock Price Statistics
The stock price has increased by +249.62% in the last 52 weeks. The beta is 0.31, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +249.62% |
| 50-Day Moving Average | 13.60 |
| 200-Day Moving Average | 9.71 |
| Relative Strength Index (RSI) | 63.12 |
| Average Volume (20 Days) | 146,491 |
Short Selling Information
The latest short interest is 101,226, so 0.33% of the outstanding shares have been sold short.
| Short Interest | 101,226 |
| Short Previous Month | 99,305 |
| Short % of Shares Out | 0.33% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.57 |
Income Statement
In the last 12 months, BrainsWay had revenue of $52.23 million and earned $7.58 million in profits. Earnings per share was $0.18.
| Revenue | 52.23M |
| Gross Profit | 39.39M |
| Operating Income | 4.32M |
| Pretax Income | 7.71M |
| Net Income | 7.58M |
| EBITDA | 5.12M |
| EBIT | 4.32M |
| Earnings Per Share (EPS) | $0.18 |
Balance Sheet
The company has $67.70 million in cash and $6.82 million in debt, giving a net cash position of $60.88 million or $1.52 per share.
| Cash & Cash Equivalents | 67.70M |
| Total Debt | 6.82M |
| Net Cash | 60.88M |
| Net Cash Per Share | $1.52 |
| Equity (Book Value) | 73.16M |
| Book Value Per Share | 1.87 |
| Working Capital | 61.33M |
Cash Flow
In the last 12 months, operating cash flow was $17.49 million and capital expenditures -$2.34 million, giving a free cash flow of $15.15 million.
| Operating Cash Flow | 17.49M |
| Capital Expenditures | -2.34M |
| Depreciation & Amortization | 793,000 |
| Net Borrowing | -832,000 |
| Free Cash Flow | 15.15M |
| FCF Per Share | $0.38 |
Margins
Gross margin is 75.42%, with operating and profit margins of 8.28% and 14.50%.
| Gross Margin | 75.42% |
| Operating Margin | 8.28% |
| Pretax Margin | 14.76% |
| Profit Margin | 14.50% |
| EBITDA Margin | 9.80% |
| EBIT Margin | 8.28% |
| FCF Margin | 29.01% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.91% |
| Shareholder Yield | -13.91% |
| Earnings Yield | 1.16% |
| FCF Yield | 2.32% |
Analyst Forecast
The average price target for BrainsWay is $13.25, which is -17.70% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.25 |
| Price Target Difference | -17.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 4, 2026. It was a forward split with a ratio of 2:1.
| Last Split Date | Mar 4, 2026 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BrainsWay has an Altman Z-Score of 3.73 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.73 |
| Piotroski F-Score | 5 |